Evaluation of pomegranate peel extract in bladder infectio
Phase 3
Recruiting
- Conditions
- Cystitis.Cystitis, unspecifiedN30.9
- Registration Number
- IRCT20200408046990N15
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Acute cystitis based on clinical symptoms
Signing a written informed consent
Exclusion Criteria
Simultaneous use of phenazopyridine
Taking cranberry and probiotic supplements
History of allergy to pomegranate and its derivatives
Taking warfarin or cyclosporine and tacrolimus
History of severe constipation or hemorrhoids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of improvement of disease symptoms. Timepoint: At the beginning of the study and then at the end of the third, fifth day and if the symptoms remain, on the seventh day. Method of measurement: Acute cystitis symptom scoring criteria evaluation questionnaire (ACSS).
- Secondary Outcome Measures
Name Time Method